Amplify US Alternative Harvest ETF

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

WEED

MJUS

MSOS

TOKE

The recent move by the administration to ease federal regulations on medical marijuana is offering substantial tax breaks to numerous cannabis companies. This change has the potential to attract significant investment into the growing sector.

Unusual Whales

Roundhill Cannabis ETF

Amplify Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

Cambria Cannabis ETF

New regulations under Trump offer tax breaks for cannabis companies, attracting investment to the growing industry.

TLRY

Cannabis ETFs surged following reports of a potential Schedule III reclassification of marijuana by the Trump administration. Stocks of companies like Tilray and Canopy Growth rose significantly, with ETFs such as AdvisorShares Pure US Cannabis ETF gaining over 25%. This reclassification could alleviate tax burdens for U.S. cannabis companies, enhancing profitability and attracting institutional investment. The rally raises questions about whether it signals a lasting turnaround for the cannabis sector or is merely a temporary spike driven by policy changes.

benzinga_article

Canopy Growth

Tilray Brands

Trump's Marijuana Reclassification Plan Sparks Cannabis ETF Rally—Is A Breakout Finally Here?

YOLO

CNBS

Cannabis providers hailed the decision, calling it the most consequential federal marijuana policy shift in decades.

AdvisorShares Pure Cannabis ETF

Amplify Seymour Cannabis ETF

Cannabis stocks lose buzz despite this landmark decision

CRLBF

MSOX

CURLF

The cannabis sector is currently in earnings season, revealing key insights from company executives. A significant catalyst is the potential rescheduling of cannabis to Schedule III, which would enhance cash flow by allowing expense deductions. CEOs from Curaleaf and Cresco Labs emphasize that this change is likely to occur before the midterm elections, fostering broader reform and improving market conditions. Additionally, the closure of a federal loophole allowing hemp-derived THC products is expected to stabilize prices and shift consumers back to regulated markets, benefiting cannabis companies in the long run.

CabotWealthNetwork

Cresco Labs Inc.

AdvisorShares MSOS 2x Daily ETF

Curaleaf Holdings, Inc.

Key Cannabis Sector Investing Insights from the Latest Earnings Calls

In Seattle on February 24th, 2026, Leading Retirement Solutions (LRS), a prominent cannabis 401(k) provider for over ten years, unveiled the pioneering Cannabis Industry Retirement Report. This release is significant for an industry that has traditionally experienced a lack of comprehensive data.

Leading Retirement Solutions (LRS) releases first Cannabis Industry Retirement Report after a decade, marking a crucial milestone.

Leading Retirement Solutions (LRS) has released the first comprehensive Cannabis Industry Retirement Report, analyzing 140 cannabis 401(k) plans across over 420 entities, representing 17,000 participants and $71 million in assets. Key findings include 74% of plans offering auto-enrollment, with nearly 40% employee participation. The report highlights the industry's progress in providing competitive retirement benefits, which are becoming essential for attracting talent. Additionally, recent federal policy changes may enhance financial stability for cannabis operators, allowing for better employee benefits. This marks a significant shift in the cannabis industry's approach to retirement planning.

prnewswire

11:42 ETA New Era for Cannabis: Inside the First Industry Retirement Report

IIPR

GTBIF

The paper wrote that the U.S. has “gone too far” in normalizing usage of the drug.

Innovative Industrial Properties

Green Thumb Industries Inc.

New York Times editorial board calls for guardrails for marijuana after backing legalization

The U.S. Hemp Roundtable has welcomed the introduction of the bipartisan Hemp Enforcement, Modernization, and Protection (HEMP) Act, led by Rep. Morgan Griffith and Rep. Marc Veasey. This legislation aims to establish a federal regulatory framework for hemp-derived products under the FDA, enhancing consumer protections and providing regulatory clarity. The Act addresses the current lack of federal oversight, which has resulted in inconsistent state regulations. The U.S. Hemp Roundtable emphasizes the need for a two-year extension of the hemp ban moratorium to facilitate the passage of this critical legislation.

16:30 ET
			
			
				U.S. Hemp Roundtable Welcomes Rep. Morgan Griffith's Bipartisan HEMP Act to Establish Federal Regulatory Framework for Hemp-Derived Products

Amplify US Alternative Harvest ETF(MJUS.US)